Gabapentin
- Generic Name
- Gabapentin
- Brand Names
- Gralise, Neurontin
- Drug Type
- Small Molecule
- Chemical Formula
- C9H17NO2
- CAS Number
- 60142-96-3
- Unique Ingredient Identifier
- 6CW7F3G59X
- Background
Gabapentin is a structural analogue of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) that was first approved for use in the United States in 1993. It was originally developed as a novel anti-epileptic for the treatment of certain types of seizures - today it is also widely used to treat neuropathic pain. Gabapentin has some stark advantages ...
- Indication
In the United States, gabapentin is officially indicated for the treatment of postherpetic neuralgia in adults and for the adjunctive treatment of partial-onset seizures, with or without secondary generalization, in patients 3 years of age and older. In Europe, gabapentin is indicated for adjunctive therapy in the treatment of partial-onset seizures, with or...
- Associated Conditions
- Partial-Onset Seizures, Peripheral Neuropathic Pain, Postherpetic Neuralgia
- Associated Therapies
- -
Gabapentin for Carpal Tunnel Syndrome
- First Posted Date
- 2005-08-30
- Last Posted Date
- 2007-10-31
- Lead Sponsor
- Chinese University of Hong Kong
- Target Recruit Count
- 150
- Registration Number
- NCT00137735
- Locations
- 🇭🇰
Prince of Wales Hospital, Shatin, New Territories, Hong Kong
🇭🇰North District Hospital, Sheung Shui, New Territories, Hong Kong
Gabapentin for the Treatment of Hot Flashes in Menopausal Women
- Conditions
- First Posted Date
- 2005-05-30
- Last Posted Date
- 2011-05-23
- Lead Sponsor
- North Toronto Primary Care Research Network
- Target Recruit Count
- 200
- Registration Number
- NCT00112138
- Locations
- 🇨🇦
The Scarborough Hospital, Scarborough, Ontario, Canada
Chronic Low Back Pain Research Project
- First Posted Date
- 2005-04-18
- Last Posted Date
- 2014-02-10
- Lead Sponsor
- US Department of Veterans Affairs
- Target Recruit Count
- 108
- Registration Number
- NCT00108550
- Locations
- 🇺🇸
VA San Diego Healthcare System, San Diego, San Diego, California, United States
Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone Therapy
- First Posted Date
- 2004-07-12
- Last Posted Date
- 2016-07-14
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 118
- Registration Number
- NCT00087399
- Locations
- 🇺🇸
Bismarck Cancer Center, Bismarck, North Dakota, United States
🇺🇸John and Dorothy Morgan Cancer Center at Lehigh Valley Hospital, Allentown, Pennsylvania, United States
🇺🇸Galesburg Clinic, Galesburg, Illinois, United States
Gabapentin to Treat Itch in Patients With Liver Disease
- Conditions
- Interventions
- First Posted Date
- 2003-04-16
- Last Posted Date
- 2017-10-13
- Target Recruit Count
- 15
- Registration Number
- NCT00058890
- Locations
- 🇺🇸
Columbia University College of Physicians and Surgeons, New York, New York, United States
Gabapentin in Fibromyalgia Trial (GIFT)
- Conditions
- First Posted Date
- 2003-03-31
- Last Posted Date
- 2007-12-19
- Target Recruit Count
- 150
- Registration Number
- NCT00057278
- Locations
- 🇺🇸
University of Cincinnati College of Medicine, Department of Psychiatry (must live in the Cincinnati, OH area), Cincinnati, Ohio, United States
🇺🇸McLean Hospital/Harvard Medical School (must live in the Boston, MA area), Belmont, Massachusetts, United States
🇺🇸Newton-Wellesley Hospital (must live in the Boston, MA area), Newton, Massachusetts, United States
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2016-06-28
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 223
- Registration Number
- NCT00028574
- Locations
- 🇺🇸
Mobile Infirmary Medical Center, Mobile, Alabama, United States
🇺🇸Eureka Community Hospital, Eureka, Illinois, United States
🇺🇸Graham Hospital, Canton, Illinois, United States
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2015-10-15
- Lead Sponsor
- Gary Morrow
- Registration Number
- NCT00022074
- Locations
- 🇺🇸
CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States
🇺🇸CCOP - Northern New Jersey, Hackensack, New Jersey, United States
🇺🇸MBCCOP - Gulf Coast, Mobile, Alabama, United States
Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2016-07-04
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 100
- Registration Number
- NCT00027963
- Locations
- 🇺🇸
CentraCare Health Plaza, Saint Cloud, Minnesota, United States
🇨🇦Allan Blair Cancer Centre, Regina, Saskatchewan, Canada
🇺🇸Mayo Clinic, Jacksonville, Florida, United States
Specific Interventions for Agitation in Alzheimer's Disease
- Conditions
- First Posted Date
- 2001-07-05
- Last Posted Date
- 2009-01-21
- Lead Sponsor
- US Department of Veterans Affairs
- Registration Number
- NCT00018291
- Locations
- 🇺🇸
Palo Alto VA Health Care System, Menlo Park, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.